Healthcare provider profile · identity verified

Charles M Perricone, MD

Family Practice · HENDERSON, TX · NPI 1659345353

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	410	123
Amlodipine Besylate	Amlodipine Besylate	393	106
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	336	53
Gabapentin	Gabapentin	281	75
Simvastatin	Simvastatin	211	60
Valsartan	Valsartan	207	52
Lisinopril	Lisinopril	205	58
Tamsulosin Hcl	Tamsulosin Hcl	205	62
Furosemide	Furosemide	200	64
Levothyroxine Sodium	Levothyroxine Sodium	197	51
Alprazolam	Alprazolam	176	20
Carvedilol	Carvedilol	173	47
Rosuvastatin Calcium	Rosuvastatin Calcium	170	41
Albuterol Sulfate Hfa	Albuterol Sulfate	157	31
Hydrochlorothiazide	Hydrochlorothiazide	155	50
Lorazepam	Lorazepam	153	27
Metformin Hcl	Metformin Hcl	149	47
Tramadol Hcl	Tramadol Hcl	148	42
Omeprazole	Omeprazole	144	46
Potassium Chloride	Potassium Chloride	141	42
Losartan Potassium	Losartan Potassium	134	37
Metoprolol Succinate	Metoprolol Succinate	134	41
Zolpidem Tartrate	Zolpidem Tartrate	133	22
Pantoprazole Sodium	Pantoprazole Sodium	132	39
Jardiance	Empagliflozin	130	29
Sertraline Hcl	Sertraline Hcl	126	39
Celecoxib	Celecoxib	112	35
Montelukast Sodium	Montelukast Sodium	107	30
Clopidogrel	Clopidogrel Bisulfate	105	31
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	94	28
Glimepiride	Glimepiride	91	28
Pravastatin Sodium	Pravastatin Sodium	89	25
Ozempic	Semaglutide	87	12
Duloxetine Hcl	Duloxetine Hcl	86	23
Metoprolol Tartrate	Metoprolol Tartrate	86	25
Prednisone	Prednisone	85	45
Acetaminophen-Codeine	Acetaminophen With Codeine	83	17
Esomeprazole Magnesium	Esomeprazole Magnesium	80	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	79	suppressed
Clonazepam	Clonazepam	77	13
Donepezil Hcl	Donepezil Hcl	77	22
Allopurinol	Allopurinol	76	22
Tizanidine Hcl	Tizanidine Hcl	73	16
Eliquis	Apixaban	70	18
Meloxicam	Meloxicam	69	17
Alendronate Sodium	Alendronate Sodium	67	18
Glipizide	Glipizide	67	19
Trazodone Hcl	Trazodone Hcl	63	16
Finasteride	Finasteride	61	18
Fluticasone Propionate	Fluticasone Propionate	59	24
Irbesartan	Irbesartan	53	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	48	11
Diclofenac Sodium	Diclofenac Sodium	45	16
Triamcinolone Acetonide	Triamcinolone Acetonide	45	21
Levofloxacin	Levofloxacin	44	37
Metformin Hcl Er	Metformin Hcl	41	15
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Famotidine	Famotidine	39	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Lansoprazole	Lansoprazole	38	suppressed
Mounjaro	Tirzepatide	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Mirtazapine	Mirtazapine	37	13
Temazepam	Temazepam	37	suppressed
Digoxin	Digoxin	36	suppressed
Nitroglycerin	Nitroglycerin	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Atenolol	Atenolol	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Bydureon Bcise	Exenatide Microspheres	28	suppressed
Ezetimibe	Ezetimibe	28	11
Meclizine Hcl	Meclizine Hcl	28	suppressed
Kerendia	Finerenone	27	suppressed
Ondansetron Odt	Ondansetron	27	12
Promethazine Hcl	Promethazine Hcl	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Raloxifene Hcl	Raloxifene Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	24
Farxiga	Dapagliflozin Propanediol	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	13
Ibuprofen	Ibuprofen	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Ramipril	Ramipril	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Nabumetone	Nabumetone	23	suppressed
Diazepam	Diazepam	22	suppressed
Fluconazole	Fluconazole	22	13
Mupirocin	Mupirocin	22	14
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	12
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Indapamide	Indapamide	15	suppressed
Naproxen	Naproxen	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Colesevelam Hcl	Colesevelam Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Aripiprazole	Aripiprazole	13	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Cephalexin	Cephalexin	12	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Mesalamine Er	Mesalamine	11	suppressed
Nexletol	Bempedoic Acid	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error